CYYNF (Cynata Therapeutics) Other Current Payables: $0.00 Mil (As of Dec. 2025)


What is Cynata Therapeutics Other Current Payables?

Cynata Therapeutics CYYNF -95.96% Other Current Payables is $0.00 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Cynata Therapeutics's Other Current Payables for the quarter that ended in Dec. 2025 was $0.00 Mil.

Cynata Therapeutics's quarterly Other Current Payables increased from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($0.36 Mil) but then declined from Jun. 2025 ($0.36 Mil) to Dec. 2025 ($0.00 Mil).

Cynata Therapeutics's annual Other Current Payables declined from Jun. 2023 ($0.51 Mil) to Jun. 2024 ($0.34 Mil) but then increased from Jun. 2024 ($0.34 Mil) to Jun. 2025 ($0.36 Mil).

Cynata Therapeutics Other Current Payables Related Terms

Cynata Therapeutics Other Current Payables Historical Data

* Premium members only.

The historical data trend for Cynata Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cynata Therapeutics Other Current Payables Chart

Cynata Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.53 0.51 0.34 0.36

Cynata Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.34 0.00 0.36 0.00

Cynata Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Cynata Therapeutics (CYYNF) has a Other Current Payables of $0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cynata Therapeutics and its competitors.
Is Cynata Therapeutics' Other Current Payables too high?
Cynata Therapeutics' current Other Current Payables is $0.00 Mil.
How does Cynata Therapeutics' Other Current Payables compare to VRTX and REGN?
Cynata Therapeutics' Other Current Payables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cynata Therapeutics and its competitors. Cynata Therapeutics's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cynata Therapeutics stock overvalued right now?
Cynata Therapeutics (CYYNF) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Cynata Therapeutics (CYYNF), the current Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cynata Therapeutics Business Description

Other Exchanges 51S:GermanyCYP:Australia
Address 100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus manufacturing platform. There are currently three active clinical trials taking place using Cymerus technology, which are attempting to treat osteoarthritis and others.